Replies to post #56204 on Ocata Therapeutics Inc fka OCAT

[Stemcall]

"I would welcome a post that suggests what developments this year could help our share price and investment in this promising company."

"Thank you for your additional comments about Advanced Cell Technology, Inc and Gary Rabin. As we noted in our prior response, OIEA processes many complaints received from individual investors and others. We keep records of the correspondence we receive in a searchable database that SEC staff may make use of in inspections, examinations, and investigations. In addition, some correspondence received by OIEA is referred directly to other SEC offices and divisions for their review.

Please note the SEC conducts its investigations on a confidential and nonpublic basis and neither confirms nor denies the existence of an investigation unless the SEC brings charges against someone involved. We do this to protect the integrity and effectiveness of our investigative process and to preserve the privacy of the individuals and entities involved. As a result, we will be unable to confirm whether an investigation exists or provide you with any updates on the status of your complaint or of any pending SEC investigation. Information on our policy is enclosed. You may wish to check our website, www.sec.gov, for information about pending SEC civil actions, administrative cases, and other matters."

Sincerely,


Special Counsel
Office of Investor Education and Advocacy
U.S. Securities and Exchange Commission
[phone]
www.sec.gov